当前位置:首页 - 行情中心 - 心脉医疗(688016) - 财务分析 - 现金流量表

心脉医疗

(688016)

  

流通市值:106.19亿  总市值:106.19亿
流通股本:1.23亿   总股本:1.23亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金997,471,189.44792,952,089.86245,121,060.341,369,647,675.84
  收到的税费返还---501,911.56
  收到其他与经营活动有关的现金34,273,555.0626,006,952.232,343,741.5884,787,483.59
  经营活动现金流入小计1,031,744,744.5818,959,042.09247,464,801.921,454,937,070.99
  购买商品、接受劳务支付的现金258,698,037.34178,518,855.6974,389,722.11284,442,393.51
  支付给职工以及为职工支付的现金214,651,652.45149,109,224.4277,022,849.17283,610,959.65
  支付的各项税费172,954,788.41118,160,642.0142,619,371.92178,954,504.5
  支付其他与经营活动有关的现金113,909,997.7383,584,121.0242,750,736.63134,865,258.08
  经营活动现金流出小计760,214,475.93529,372,843.14236,782,679.83881,873,115.74
  经营活动产生的现金流量净额271,530,268.57289,586,198.9510,682,122.09573,063,955.25
二、投资活动产生的现金流量:
  收回投资收到的现金4,144,000,0002,029,000,000750,000,0004,930,000,000
  取得投资收益收到的现金14,938,722.584,961,936.611,211,896.1215,976,849.83
  处置固定资产、无形资产和其他长期资产收回的现金净额447,463.26447,463.2618,000-
  投资活动现金流入小计4,159,386,185.842,034,409,399.87751,229,896.124,945,976,849.83
  购建固定资产、无形资产和其他长期资产支付的现金161,167,709.5479,613,328.129,152,851.47303,033,026.27
  投资支付的现金4,284,000,0002,834,000,0001,640,000,0005,030,000,000
  投资活动现金流出小计4,445,167,709.542,913,613,328.11,669,152,851.475,333,033,026.27
  投资活动产生的现金流量净额-285,781,523.7-879,203,928.23-917,922,955.35-387,056,176.44
三、筹资活动产生的现金流量:
  取得借款收到的现金---126,000,000
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---126,000,000
  偿还债务支付的现金---140,000,000
  分配股利、利润或偿付利息支付的现金120,817,250.91120,841,074-201,834,960.1
  支付其他与筹资活动有关的现金8,010,660.346,068,898.013,051,198.59134,083,628.72
  筹资活动现金流出小计128,827,911.25126,909,972.013,051,198.59475,918,588.82
  筹资活动产生的现金流量净额-128,827,911.25-126,909,972.01-3,051,198.59-349,918,588.82
四、汇率变动对现金及现金等价物的影响-10,495,943.34-7,310,594.89-3,946,951.74-2,871,180.32
五、现金及现金等价物净增加额-153,575,109.72-723,838,296.18-914,238,983.59-166,781,990.33
  加:期初现金及现金等价物余额1,892,049,254.811,892,049,254.811,892,049,254.812,058,831,245.14
  期末现金及现金等价物余额1,738,474,145.091,168,210,958.63977,810,271.221,892,049,254.81
补充资料:
  净利润-317,518,865.36-554,659,959.66
  资产减值准备-5,908,932.54-9,271,248.76
  固定资产和投资性房地产折旧-4,877,581.79-13,593,988.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-4,877,581.79-13,593,988.86
  无形资产摊销-27,397,791.96-53,408,929.34
  长期待摊费用摊销-4,665,177.09-10,651,037.81
  处置固定资产、无形资产和其他长期资产的损失-70,970.84--
  固定资产报废损失---89,021
  公允价值变动损失----367,945.21
  财务费用-6,718,580.51-6,882,102.44
  投资损失--6,428,344.82--15,976,849.83
  递延所得税--10,770,541.51--11,348,913.81
  其中:递延所得税资产减少--6,905,308.88--5,372,460.42
    递延所得税负债增加--3,865,232.63--5,976,453.39
  存货的减少--39,896,645.93--14,369,865.11
  经营性应收项目的减少--93,563,064.79-90,927,824.01
  经营性应付项目的增加-57,024,099.42--159,007,774.59
  其他-6,420,739.12-14,287,357.8
  不涉及现金收支的投资和筹资活动金额其他项目---1,220,071.08
  现金的期末余额-1,168,210,958.63-1,892,049,254.81
  减:现金的期初余额-1,892,049,254.81-2,058,831,245.14
  现金及现金等价物的净增加额--723,838,296.18--166,781,990.33
公告日期2026-10-302026-08-272026-04-302026-03-31
审计意见(境内)标准无保留意见
TOP↑